BioAmber (NYSE: BIOA) reported Q1 EPS of $0.00, $0.13 better than the analyst estimate of ($0.13). Revenue for the quarter came in at $2.12 million versus the consensus estimate of $4.02 million.

For earnings history and earnings-related data on BioAmber (BIOA) click here.